Shares of Verona Pharma plc (VRP.L) (LON:VRP – Get Rating) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 55 ($0.67) and traded as high as GBX 56 ($0.68). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.67), with a volume of 70,791 shares trading hands.
Verona Pharma plc (VRP.L) Trading Up 5.8 %
The company has a market capitalization of £228.00 million and a PE ratio of -1.68. The company’s fifty day moving average is GBX 55 and its 200-day moving average is GBX 55. The company has a debt-to-equity ratio of 6.85, a current ratio of 2.99 and a quick ratio of 2.47.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.